NT-814 shows therapeutic potential in postmenopausal women with hot flashes
Treatment with the dual neurokinin 1,3 antagonist NT-814 induces prompt, marked improvements in hot flashes and waking due to night sweats in postmenopausal women, with doses up to 300 mg being well tolerated, according to the results of a trial.